# Schroder Adveq: portfolio, investments and team > Schroder Adveq is a vc firm based in Switzerland. 8 investments on record, latest Dec 2019. Portfolio, stages, co-investors and team. Source: https://millionrounds.com/fund/schroder-adveq (Millionrounds; every figure on the page links to its filing or article) Switzerland · [Investor](https://millionrounds.com/investors) # Schroder Adveq Last cheque observed Dec 2019. Silence since then is not evidence of inactivity: our sources miss unannounced rounds. Quiet New fund $161M, Jan 2021 VC firm Seed Series A Series B FinTech Market Research Real Estate Cheques on record **0%** of best year **0** **cheques in 12 months**, 8 on record Since the last cheque **2512** days **00** hrs **00** min **00** sec Median round **$44M** Rounds led **0 of 8** Mostly in **Switzerland, 50%** Pitch Schroder Adveq ## Schroder Adveq highlights - 01 8 rounds on record - 02 Mostly Series B and Series A: 63% of its rounds ## What they do > Filed 1 private fund offering with the SEC, the most recent in 2021-01 From their own website - **Type:** VC firm (from a list, unverified) - **Cheque size:** Not stated - **Stages:** Seed Series A Series B Growth Pre-IPO - **Sectors:** FinTech Market Research Real Estate - **Based in:** Zürich, Switzerland - **Cold pitches:** Not stated ## The record Every round we can evidence, newest first **8 appearances** - **2019** 4 rounds - **Dec** **[ImmunOS](https://millionrounds.com/company/immunos)** Series A · CH · FinSMEs **$15M** With 5 others - **Aug** **[Araris Biotech](https://millionrounds.com/company/araris-biotech)** Seed · CH · FinSMEs **$2.5M** With 2 others - **Jul** **[Revolution Medicines](https://millionrounds.com/company/revolution-medicines)** Series C · US · FinSMEs **$100M** With 9 others - **May** **[Alentis Therapeutics](https://millionrounds.com/company/alentis-therapeutics)** Series A · CH · FinSMEs **$13M** With 4 others - **2018** 4 rounds - **Nov** **[Amal Therapeutics](https://millionrounds.com/company/amal-therapeutics)** Series B · CH · FinSMEs **$33M** With 4 others - **Jul** **[Pliant Therapeutics](https://millionrounds.com/company/pliant-therapeutics)** Series B · US · FinSMEs **$62M** With 4 others - **Jul** **[Nohla Therapeutics](https://millionrounds.com/company/nohla-therapeutics)** Series B · US · FinSMEs **$56M** With 2 others - **Jun** **[Decibel Therapeutics](https://millionrounds.com/company/decibel-therapeutics)** Series C · US · FinSMEs **$55M** With 8 others An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor. ## The team Named by the firm itself, on a filing, its Form ADV or its company registration **9 named** BE **Bruno E. Raschle** Non-Executive Vice Chairman of the Investment Manager's Board of Directors i Filing they signed DS **David Seex** Member of the Investment Manager's Executive Committee i Filing they signed LG **Lee Gardella** Member of the Investment Manager's Management Committee i Filing they signed NE **Nils E. Rode** Member of the Investment Manager's Management Committee i Filing they signed PA **Peter Arnold** Member of the Investment Manager's Management Committee i Filing they signed PB **Philippe Bucher** Member of the Investment Manager's Executive Committee i Filing they signed RE **Rainer Ender** Member of the Investment Manager's Management Committee i Filing they signed SL **Sven Liden** Member of the Investment Manager's Executive Committee i Filing they signed TC **Tim Creed** Member of the Investment Manager's Management Committee i Filing they signed We also hold **20** people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them. New fund on file **$161M** raised in Jan 2021 From its SEC filing, not a journalist: a firm that has just raised has money to deploy. ## The cheque Seed Series A Series B Median round joined **$44M** the round, not its cheque Led 0 of 8 rounds **0%** - **Sole investor:** Never alone - **Last cheque:** Dec 2019 Rounds by stage said on their site - Series B said *3* - Series A said *2* - Series C *2* - Seed said *1* - Growth said *-* - Pre-IPO said *-* Cheques by year Led Joined 2018 2019 Often in the room with - [BioMedPartners](https://millionrounds.com/fund/biomedpartners) 2 - [HTGF High-Tech Gründerfonds](https://millionrounds.com/fund/high-tech-grunderfonds-htgf) 2 - [Redalpine](https://millionrounds.com/fund/redalpine) 2 - [Third Rock Ventures](https://millionrounds.com/fund/third-rock-ventures) 2 - [VI Partners](https://millionrounds.com/fund/vi-partners) 2 **Pitching Schroder Adveq?** Put them on your fundraising board with this record on the card, and follow them to hear when they write a new cheque. Add to your CRM *→* ## Who they invest alongside The investors most often in the same rounds as Schroder Adveq. A count of rooms they were both in, not a relationship either has claimed. [**BioMedPartners** Private equity **2** rounds together](https://millionrounds.com/fund/biomedpartners)[**HTGF High-Tech Gründerfonds** VC firm **2** rounds together](https://millionrounds.com/fund/high-tech-grunderfonds-htgf)[**Redalpine** VC firm **2** rounds together](https://millionrounds.com/fund/redalpine)[**Third Rock Ventures** VC firm **2** rounds together](https://millionrounds.com/fund/third-rock-ventures)[**VI Partners** VC firm **2** rounds together](https://millionrounds.com/fund/vi-partners) ## Recently backed The latest companies Schroder Adveq put money into. [**Araris Biotech** $2.5M · Aug 2019](https://millionrounds.com/company/araris-biotech)[**Revolution Medicines** $100M · Jul 2019](https://millionrounds.com/company/revolution-medicines)[**Alentis Therapeutics** $13M · May 2019](https://millionrounds.com/company/alentis-therapeutics)[**Nohla Therapeutics** $56M · Jul 2018](https://millionrounds.com/company/nohla-therapeutics)[**Decibel Therapeutics** $55M · Jun 2018](https://millionrounds.com/company/decibel-therapeutics) ## Quick answers about Schroder Adveq ### What does Schroder Adveq invest in? Schroder Adveq invests most often at Series B and Series A (63% of the rounds on record), in sectors such as FinTech, Market Research and Real Estate. ### How active is Schroder Adveq? 8 investments on record, 0 of them in the last 12 months. The most recent was in Dec 2019. ### What has Schroder Adveq invested in recently? Its most recent investments on record: ImmunOS (Series A, Dec 2019), Araris Biotech (Seed, Aug 2019) and Revolution Medicines (Series C, Jul 2019). ### How big are Schroder Adveq's cheques? The median round it joins is $44M. ### Does Schroder Adveq lead rounds? Rarely, if at all: none of its 8 investments on record names it as the lead. ### Where does Schroder Adveq invest? Most of the companies it backs are in Switzerland (50%) and the United States (50%). ### Is Schroder Adveq investing now? No investments in the last 12 months; the latest was in Dec 2019. ### Who does Schroder Adveq invest alongside? Most often BioMedPartners (2 rounds together), HTGF High-Tech Gründerfonds (2 rounds together) and Redalpine (2 rounds together). ## Raising now? Find the investors who back rounds like yours, and keep every conversation on one fundraising board. Find similar investorsOpen your CRM Built from the rounds we watched, its filings and its own website, refreshed every night. [How we count](https://millionrounds.com/methodology) · [Report a correction](https://millionrounds.com/corrections?slug=schroder-adveq) · [Is this your firm? Claim it](https://millionrounds.com/claim?org=schroder-adveq)